Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
11.87
+0.55 (4.86%)
At close: Mar 9, 2026, 4:00 PM EDT
12.10
+0.23 (1.94%)
After-hours: Mar 9, 2026, 6:57 PM EDT
Xencor Employees
Xencor had 260 employees as of December 31, 2025. The number of employees increased by 10 or 4.00% compared to the previous year.
Employees
260
Change (1Y)
10
Growth (1Y)
4.00%
Revenue / Employee
$482,985
Profits / Employee
-$353,550
Market Cap
870.53M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| Phathom Pharmaceuticals | 371 |
| KalVista Pharmaceuticals | 270 |
| Arvinas | 246 |
| Omeros | 202 |
| Sana Biotechnology | 194 |
| CytomX Therapeutics | 121 |
| Janux Therapeutics | 109 |
XNCR News
- 5 days ago - Xencor Announces Change to Ultomiris® Royalty Revenue Forecast - Business Wire
- 12 days ago - Xencor Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 14 days ago - Xencor to Participate at Upcoming Investor Conferences - Business Wire
- 2 months ago - Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones - Business Wire
- 2 months ago - Xencor: Fortress Balance Sheet Bodes Well For XmAb819 And XmAb942 - Seeking Alpha
- 3 months ago - Xencor Announces Extension of U.S. Patent Term on Certain Xtend™ Antibodies - Business Wire
- 4 months ago - Xencor Reports Third Quarter 2025 Financial Results - Business Wire
- 4 months ago - Xencor, Inc. (XNCR) Discusses Initial Phase I Dose Escalation Results for XmAb819 in Advanced Clear Cell Renal Cell Carcinoma Transcript - Seeking Alpha